(Q39120205)

English

Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer

scientific article published on 26 July 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Shigenobu Emoto

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Hironori Yamaguchi

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Takao Kamei

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Hironori Ishigami

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Takashi Suhara

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Yukimitsu Suzuki

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Taichi Ito

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Joji Kitayama

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Toshiaki Watanabe

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

26 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

919-926

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Recent results of therapy for scirrhous gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Treatment of peritoneal carcinomatosis in gastric cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Drug delivery systems for intraperitoneal therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Intraperitoneal antineoplastic drug delivery: rationale and results

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Pharmacologic principles of intraperitoneal chemotherapy for the treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Environment-sensitive hydrogels for drug delivery

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Suppression of in vivo tumor growth by using a biodegradable thermosensitive hydrogel polymer containing chemotherapeutic agent

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Hyaluronan: pharmaceutical characterization and drug delivery

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Injectable hyaluronic acid microhydrogels for controlled release formulation of erythropoietin.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

The prevention of peritoneal adhesions by in situ cross-linking hydrogels of hyaluronic acid and cellulose derivatives

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Endothelial adhesion of synchronized gastric tumor cells changes during cell cycle transit and correlates with the expression level of CD44 splice variants.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit repeated-injury model.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) in peritoneal metastatic nodules.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0674-6

21 January 2018

Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23887848

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/23887848

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/23887848

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraperitoneal drug delivery for ovarian cancer: why, how, who, what, and when?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23887848

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23887848

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

pH effect on the synthesis, shear properties, and homogeneity of iron‐crosslinked hyaluronic acid‐based gel/adhesion barrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/23887848

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug release behaviors of a pH sensitive semi-interpenetrating polymer network hydrogel composed of poly(vinyl alcohol) and star poly[2-(dimethylamino)ethyl methacrylate]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23887848

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23887848

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/23887848

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intra-peritoneal administration of paclitaxel with non-animal stabilized hyaluronic acid as a vehicle--a new strategy against peritoneal dissemination of gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23887848

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00595-013-0674-6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39120205&oldid=1808306137"